We previously investigated the inactivation of endothelin-1 by deamidase (lysosomal protective protein), present in many cells, including vascular smooth muscle cells. This enzyme, which we originally purified from human platelets, preferentially hydrolyzes peptides at the C-termlnus with hydrophobic amino adds in the Pi or P,' position or both and thereby inactivates endothelin-1, which has a C-tenninal sequence of Ile"-Ile 
ndothelin-1 (ET-1) is the most potent naturally occurring peptide that contracts vascular smooth muscle, causing a long-lasting increase in blood pressure. Because ET-1 is synthesized in endothelial cells 1 and is released in a preferentially polar direction toward underlying smooth muscle, 2 a role for ET-1 in the control of blood pressure has been hypothesized. 3 ' 4 Recently, we isolated and characterized an enzyme from human platelets that has deamidase, carboxypeptidase, and esterase activities. 5 - 6 We named the enzyme deamidase because it deamidates peptides such as tachykinins, converting Met"-NH 2 to Met-OH and thereby inactivating them. Although deamidase and esterase activities are highest at neutral pH, the optimal pH for carboxypeptidase activity lies in the acid range as shown with substrates such as angiotensin I and bradykinin. 5 Partial sequencing of this human serine carboxypeptidase revealed that it is identical with the so-called lysosomal protective protein 7 and that its physical and enzymatic characteristics are similar to those reported for cathepsin A. 5 From the Laboratory of Peptide Research and Departments of Pharmacology (H.LJ., G.BJ., RA.S., E.G.E.), Anesthesiology (S.F.R., R.A.S., E.G.E.), and Biochemistry (P.W. Deamidase preferentially cleaves naturally occurring substrates where the P, and/or P,' amino acid is hydrophobic and synthetic substrates with hydrophobic amino acids in the P, and P 2 or P, and P,' positions. 36 Because the structure of ET-1 combines these elements at its C-terminus (-Ile'^Ile^Trp 21 ), we tested it with the purified enzyme and found ET-1 to be an excellent substrate for deamidase, yielding the inactive des-tryptophan 21 -ET-l as the major product. 6 Here we report that ET-1, which is primarily synthesized in endothelial cells,*-8 is inactivated by deamidase present in these cells.
Methods

Materials
5 -Dimethylaminonaphthalene -1 -sulfonyl -L -phenylalanyl-L-leucyl-L-arginine (dansyl-Phe-Leu-Arg) was synthesized by coupling dansyl-Phe to Leu-Arg using standard techniques. 6 Diisopropyl fluorophosphate (DFP), fra/w-epoxysuccinyl-L-leucylamido(4-guanidino)-butane (E-64), p-chloromercuribenzenesulfonate (PCMS), Ntosyl-Phe-chloromethyl ketone (TPCK), and other laboratory reagents were obtained from Sigma Chemical Co., St. Louis, Mo., and benzyloxycarbonyl (Zj-Gly-Leu-Phe-CH 2 Q (CK8) was from Enzyme Systems Products, Livermore, Calif.
Cell Preparation
Bovine aortic endothelial cells (BAE) were established as a primary cell culture and subcultured before use. The BAE were then harvested, homogenized by sonication, and subjected to a subcellular fractionation.
The final soluble fraction (S3) after centrifugation at 100,000g for 60 minutes was used as the source of deamidase.
When the total activity in cells was measured, BAE were harvested, counted, homogenized by sonication, and treated with 3-[(3-cholamidopropyl)dimethylammonio]-l-propane-sulfonate (CHAPS) detergent (1%). The supernatant after centrifugation at 16,000g for 10 minutes was then the source of deamidase.
Enzyme Assays
Deamidase activity with ET-1 as substrate was determined by high performance liquid chromatography (HPLC) 56 with a 30-minute gradient of 15% to 45% acetonitrile containing 0.05% trifluoroacetic acid. Reaction mixtures contained BAE-S3 fraction, 10 /xmol/L ET-1, 100 mmol/L buffer (sodium acetate at pH 5.5 or
[HEPES] at pH 7.4), and water to 100 tiL. Reactions were carried out at 23°C for 10 or 30 minutes and stopped with an equal volume of ethyl alcohol. Inhibitors were preincubated in the reaction mixture at 23°C for 15 minutes before the addition of ET-1. Deamidase activity is taken as the difference in activity in the presence and absence of its inhibitor, 1 mmol/L DFP.
The carboxypeptidase activity of deamidase was further assessed with dansyl-Phe-Leu-Arg. 6 Each reaction tube contained BAE (either S3 or total cell preparation), 100 mmol/L sodium acetate, pH 5.5, 200 /nmol/L dansyl-Phe-Leu-Arg, and water to 250 (iL final volume. Reaction mixtures were incubated at 37°C for 30 minutes and stopped with 150 /xL of 1 M citric acid, pH 3.1. The reaction product was extracted into 1 mL of chloroform, and the fluorescence was measured at 340 nm excitation and 495 nm emission wavelengths. Deamidase activity was taken as the difference in fluorescence between reactions done in the presence and absence of its inhibitor, 1 mmol/L DFP.
Amino Acid Analysis of Des-Trp 2 '-Endothelin-1
Enzymatic reactions using BAE-S3 and ET-1 (35 /imol/L) were run in the presence and absence of 1 mmol/L DFP as described above. Aliquots were fractionated by HPLC, and the product and substrate peaks were collected. Amino acid analysis by coupled 6N HC1 hydrolysis/phenylisothiocyanate derivatization was performed on an Applied Biosystems Inc. 420H/130 instrument. Hydrolysis was done in the presence of 1-dodecanethiol scavenger to afford tryptophan recovery ranging from 45% to 55% at 250 pmol input.
Bioassay
The inactivation of ET-1 by the S3 fraction of BAE at pH 5.5 was determined in a bioassay using rat aortic strips denuded of endothelial cells. The enzymatic reaction was carried out as described for ET-1, but it was stopped by cooling to 4°C. Aliquots of the reaction mixtures were added to the tissue bath (250 pmol/L of ET-1) containing the rat aortic strip, and isotonic contractions were recorded; parallel samples of the reaction mixture were analyzed in the HPLC system. 
Results
Cleavage of Endothelin-1
The S3 fraction, the final supernatant of homogenized BAE, cleaved ET-1 at a considerable rate. At 23°C and pH 5.5, 5.9±1.2 nmol was hydrolyzed in 1 minute by 1 mg protein as established by the decrease in the authentic ET-1 substrate peak in HPLC (Figure 1) . The hydrolysis of ET-1 at pH 7.4 was less than 10% of the activity seen at pH 5.5. The enzymatic activity was characterized further by using inhibitors (Table 1) . DFP (1 mmol/L) completely abolished the appearance of a new peak, attributed to the product des-Trp 21 -ET-l, and reduced the overall inactivation by 70%. CK8, TPCK, and PCMS inhibited 99%, 84%, and 75%, respectively. 5 On the other hand, E-64 and pepstatin inhibited only 10% to 32% of the hydrolysis of ET-1. Thus, because of the inhibitor profile and assay conditions, it was concluded that 70% to 80% of the ET-1 inactivation by crude endothelial cell supernatant is caused by deamidase and 10% to 30% by another, possibly a catheptic, enzyme.
Amino Acid Analysis
The major product detected by HPLC after ET-1 hydrolysis was identified as des-Trp 21 -ET-l by amino acid analysis. When the peak was collected and its amino acid content analyzed, we found that the new peak contained all the amino acids in the same molar ratios as the ET-1 standard but was lacking tryptophan. Because the peptide hydrolysis was carried out under conditions designed to protect the sensitive tryptophan residue and ET-1 contains only one tryptophan at its C-terminal end, it was concluded that ET-1 is hydrolyzed by the deamidase of endothelial cells by removing a single amino acid, Trp 21 .
Cleavage of Dansyl-Phe-Leu-Arg
The crude homogenate and the final supernatants (S3) both cleaved the deamidase substrate dansyl-PheLeu-Arg by releasing arginine. The rate for the former extract was 1.3 ±0.3 nmol/min per 10 6 cells (averaging 0.2 mg of protein per 10 6 cells). The S3 fraction hydrolyzed this substrate at a rate of 7.3±3.2 nmol/min per milligram of protein. The inhibition of this reaction was similar to that of ET-1. DFP and PCMS in 1 mmol/L concentration inhibited the reaction 81% and 80%, respectively, whereas E-64 (0.2 mmol/L) inhibited only 14%. Thus, approximately 80% of the activity can be attributed to deamidase in the cells.
Bioassay
The inactivation of the vasoconstrictor effect of ET-1 by deamidase was demonstrated on the isolated suspended rat aortic strip (Figure 2) . Incubation of ET-1 with the S3 fraction destroyed its long-lasting vasoconstrictor effect. This inactivation of aortic strip contraction was blocked by added DFP. Thus, in agreement with the results described above, the cleavage of the C-terminal tryptophan by endothelial cell deamidase inactivated the effect of ET-1 on the blood vessel.
Discussion
Deamidase is a two-chain serine peptidase, which has three different types of activity. 5 At neutral pH it hydrolyzes ester bonds and deamidates C-terminal amino acids; for example, it converts substance P (Met"-NH 2 ) to substance P-free acid (Met"-OH) or enkephalinamide to enkephalin. It is also a carboxypeptidase that can cleave free and protected C-terminal amino acids; for example, it releases Gly'-NH 2 of oxytocin. 5 The carboxypeptidase activity is more effective at an acid pH.
After deamidase was purified from human platelets and the first 25 amino acids of each chain were sequenced, the identity with the so-called lysosomal protective protein was established. 5 ' 7 Although this protein can form a high molecular weight complex with /3-galactosidase and neuramidase in lysosomes, a noncomplexed form is released by thrombin from human platelets. 5 The lack of the mature protein can cause a genetically determined disease, /3-galactosialidosis. Besides being present in platelets 5 or fibroblasts, 7 the enzyme is present in other cells, for example, in smooth muscle cells. 6 These experiments demonstrated that 70% to 80% of the inactivation of endothelin by the final supernatant of endothelial cells can be attributed to deamidase. The additional enzymes that contribute to the residual activity were not characterized further.
Deamidase also shares properties in common with cathepsin A, and as a serine carboxypeptidase, belongs to a family of enzymes together with yeast carboxypeptidase Y, KEX-1 gene product, 5 ' 7 plant carboxypeptidases, 9 and human prolylcarboxypeptidase. 10 The current and previous experiments 6 show that deamidase inactivates ET-1 by removing a single amino acid, Trp 21 . The newly revealed C-terminal Ile 19 -Ile^-OH seems to be resistant to further degradation under our conditions. The goal of this investigation was to determine if deamidase is present in endothelial cells. The identity of the inactivator of ET-1 in endothelial cells with deamidase was shown by HPLC analysis and by amino acid analysis of the reaction products, by using inhibitors, and by the cleavage of a fluorescent substrate of the enzyme. Because of the affinity of deamidase for hydrophobic amino acids, especially in the P, position, it is inhibited by some but not all inhibitors of chymotrypsin-type enzymes such as cathepsin G. 5 Thus, chymostatin or (Zj-Gly-Leu-Phe-CH 2 C1 inhibits the deami-dase, but lima bean trypsin inhibitor does not. DansylPhe-Leu-Arg is cleaved rapidly by endothelial cell deamidase, and the inhibition pattern of this reaction is similar to that of ET-1 hydrolysis.
Vascular endothelial cells as the source of ET-1 inactivator are of special interest, because besides releasing endothelins, 348 they also contain receptors for ET-1.
811 Because the inactivation of ET-1 proceeds at an acid pH (5.5) much faster than at neutral pH, 6 deamidase, as a lysosomal enzyme, probably inactivates ET-1 intracellularly after it is taken up by receptormediated endocytosis. 8 ' 12 On the other hand, it could also be present on the cell membrane of endothelial cells, as we have noticed with granular cathepsin G, which is also active on the plasma membrane of granulocytes. 13 Neutral endopeptidase 24.11 or enkephalinase (NEP) also inactivates ET-1 by cleaving at two internal peptide bonds 1415 different from the bond of the C-terminal amino acid split by deamidase. Under our conditions, NEP did not participate in the inactivation of ET-1, as suggested by the fact that its inhibitor, phosphoramidon, did not block the reaction observed (not shown) at an acidic or neutral pH -the latter is optimal for NEP. Furthermore, EDTA did not block ET-1 hydrolysis as reported here. We have demonstrated in other studies that the concentration of NEP in vascular endothelial cells is very low. 16 NEP as a plasma membrane-bound enzyme could contribute to ET-1 inactivation at the subendothelial level, for example, on the vascular smooth muscle cells.
In conclusion, vascular endothelial cells, besides being a site of origin for ET-1 and containing its receptors, also have a potent inactivator of the peptide, deamidase, which removes its C-terminal tryptophan. 6 ' 17
